未登录

P

Po-Hsuan Su

taipei medical university

H指数:18

被引数:1,225

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A DNA methylation assay (MPap) using self-collected tampon versus cytology collection swab for endometrial cancer detection

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

IF2.4

2025-12-010

OAAI

Exploring potential methylation markers for ovarian cancer from cervical scraping samples

探索宫颈癌刮片样本中卵巢癌潜在甲基化标志物

IF4.3

2025-05-170

OA

In vitro drug testing using patient-derived ovarian cancer organoids (vol 17, 194, 2024)

JOURNAL OF OVARIAN RESEARCH

IF4.2

2024-12-050

OAAI

In vitro drug testing using patient-derived ovarian cancer organoids

使用患者来源的卵巢癌类器官进行体外药物测试

JOURNAL OF OVARIAN RESEARCH

IF4.2

2024-10-021

OAAI

Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor

IF6.6

2024-06-171

OAAI

Preventive healthcare policies in the US: solutions for disease management using Big Data Analytics

JOURNAL OF BIG DATA

IF6.4

2020-06-2319

OAAI

Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings

CLINICAL EPIGENETICS

IF4.4

2019-11-2841

OAAI

Ovarian cancer detection by DNA methylation in cervical scrapings

CLINICAL EPIGENETICS

IF4.4

2019-11-2725

OAAI

Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer

SCIENTIFIC REPORTS

IF3.9

2019-06-2436

OAAI

TET1 promotes 5hmC-dependent sternness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions

TET1在宫颈癌前病变中促进5hmc依赖性的干细胞性，并抑制5hmc非依赖性的上皮-间质转化

IF10.1

2019-05-0135

PREAI

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

JOURNAL OF PATHOLOGY

IF5.2

2019-04-2330

OAAI

GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells

GATA3作为卵巢高级别浆液性癌干细胞的主要调节因子和治疗靶点

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2018-10-0331

OAAI

Epigenetic loss of heparan sulfate 3-O-sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2018-08-0910

OAAI

Methylomics profiling reveals epigenetically silenced HS3ST2 sensitize IL6 signaling and confers poor prognosis of ovarian cancer

CANCER RESEARCH

IF16.6

2017-07-011

PRE

Genotype-specific methylation of HPV in cervical intraepithelial neoplasia

宫颈上皮内瘤变中HPV的基因型特异性甲基化

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2017-01-0124

OAAI

Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm

IF3.4

2015-05-1927

OAAI

Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2013-12-1767

PREAI

Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients

HUMAN MOLECULAR GENETICS

IF3.2

2013-11-2055

OA

An epigenetic vicious cycle of DNMT, protein Tyrosine phosphatase receptor type R, and the MAPK pathway in cancer metastasis

CANCER RESEARCH

IF16.6

2011-04-010

PRE

Quantitative DNA Methylation Analysis Detects Cervical Intraepithelial Neoplasms Type 3 and Worse

定量DNA甲基化分析检测宫颈上皮内肿瘤3型及以下

IF5.1

2010-06-0886

PREAI